Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations

Kelly Metcalfe, Jan Lubinski, Henry T. Lynch, Parviz Ghadirian, William D. Foulkes, Charmaine Kim-Sing, Susan Neuhausen, Nadine Tung, Barry Rosen, Jacek Gronwald, Peter Ainsworth, Kevin Sweet, Andrea Eisen, Ping Sun, Steven A. Narod

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

Women who carry a deleterious mutation in BRCA1 or BRCA2 have high lifetime risks of breast and ovarian cancers. However, the influence of a family history of these cancers on these risks in women with BRCA mutations is unclear. We calculated cancer incidence rates for a multinational cohort comprising 3011 women with BRCA1 or BRCA2 mutations who were followed up for a mean of 3.9 years, during which time 243 incident breast or ovarian cancers were recorded. The 10-year cumulative risks of breast cancer were 18.1% (95% confidence interval [CI] = 13.3% to 22.8%) for women with a BRCA1 mutation and 15.2% (95% CI = 9.1% to 21.2%) for women with a BRCA2 mutation. Among women with a BRCA1 mutation, the risk of breast cancer increased by 1.2-fold for each first-degree relative with breast cancer before age 50 years (hazard ratio [HR] = 1.21; 95% confidence interval [CI] = 0.94 to 1.57) and the risk of ovarian cancer increased by 1.6 fold for each first- or second-degree relative with ovarian cancer (HR = 1.61; 95% CI = 1.21 to 2.14). Among women with a BRCA2 mutation, the risk of breast cancer increased by 1.7-fold for each first-degree relative younger than 50 years with breast cancer (HR = 1.67; 95% CI = 1.04 to 2.07).

Original languageEnglish
Pages (from-to)1874-1878
Number of pages5
JournalJournal of the National Cancer Institute
Volume102
Issue number24
DOIs
StatePublished - Dec 15 2010

Fingerprint

Breast Neoplasms
Mutation
Ovarian Neoplasms
Confidence Intervals
Neoplasms
Incidence

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Metcalfe, K., Lubinski, J., Lynch, H. T., Ghadirian, P., Foulkes, W. D., Kim-Sing, C., ... Narod, S. A. (2010). Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. Journal of the National Cancer Institute, 102(24), 1874-1878. https://doi.org/10.1093/jnci/djq443

Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. / Metcalfe, Kelly; Lubinski, Jan; Lynch, Henry T.; Ghadirian, Parviz; Foulkes, William D.; Kim-Sing, Charmaine; Neuhausen, Susan; Tung, Nadine; Rosen, Barry; Gronwald, Jacek; Ainsworth, Peter; Sweet, Kevin; Eisen, Andrea; Sun, Ping; Narod, Steven A.

In: Journal of the National Cancer Institute, Vol. 102, No. 24, 15.12.2010, p. 1874-1878.

Research output: Contribution to journalArticle

Metcalfe, K, Lubinski, J, Lynch, HT, Ghadirian, P, Foulkes, WD, Kim-Sing, C, Neuhausen, S, Tung, N, Rosen, B, Gronwald, J, Ainsworth, P, Sweet, K, Eisen, A, Sun, P & Narod, SA 2010, 'Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations', Journal of the National Cancer Institute, vol. 102, no. 24, pp. 1874-1878. https://doi.org/10.1093/jnci/djq443
Metcalfe, Kelly ; Lubinski, Jan ; Lynch, Henry T. ; Ghadirian, Parviz ; Foulkes, William D. ; Kim-Sing, Charmaine ; Neuhausen, Susan ; Tung, Nadine ; Rosen, Barry ; Gronwald, Jacek ; Ainsworth, Peter ; Sweet, Kevin ; Eisen, Andrea ; Sun, Ping ; Narod, Steven A. / Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. In: Journal of the National Cancer Institute. 2010 ; Vol. 102, No. 24. pp. 1874-1878.
@article{b651775b92e84352b34b00e7c431f7d0,
title = "Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations",
abstract = "Women who carry a deleterious mutation in BRCA1 or BRCA2 have high lifetime risks of breast and ovarian cancers. However, the influence of a family history of these cancers on these risks in women with BRCA mutations is unclear. We calculated cancer incidence rates for a multinational cohort comprising 3011 women with BRCA1 or BRCA2 mutations who were followed up for a mean of 3.9 years, during which time 243 incident breast or ovarian cancers were recorded. The 10-year cumulative risks of breast cancer were 18.1{\%} (95{\%} confidence interval [CI] = 13.3{\%} to 22.8{\%}) for women with a BRCA1 mutation and 15.2{\%} (95{\%} CI = 9.1{\%} to 21.2{\%}) for women with a BRCA2 mutation. Among women with a BRCA1 mutation, the risk of breast cancer increased by 1.2-fold for each first-degree relative with breast cancer before age 50 years (hazard ratio [HR] = 1.21; 95{\%} confidence interval [CI] = 0.94 to 1.57) and the risk of ovarian cancer increased by 1.6 fold for each first- or second-degree relative with ovarian cancer (HR = 1.61; 95{\%} CI = 1.21 to 2.14). Among women with a BRCA2 mutation, the risk of breast cancer increased by 1.7-fold for each first-degree relative younger than 50 years with breast cancer (HR = 1.67; 95{\%} CI = 1.04 to 2.07).",
author = "Kelly Metcalfe and Jan Lubinski and Lynch, {Henry T.} and Parviz Ghadirian and Foulkes, {William D.} and Charmaine Kim-Sing and Susan Neuhausen and Nadine Tung and Barry Rosen and Jacek Gronwald and Peter Ainsworth and Kevin Sweet and Andrea Eisen and Ping Sun and Narod, {Steven A.}",
year = "2010",
month = "12",
day = "15",
doi = "10.1093/jnci/djq443",
language = "English",
volume = "102",
pages = "1874--1878",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "24",

}

TY - JOUR

T1 - Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations

AU - Metcalfe, Kelly

AU - Lubinski, Jan

AU - Lynch, Henry T.

AU - Ghadirian, Parviz

AU - Foulkes, William D.

AU - Kim-Sing, Charmaine

AU - Neuhausen, Susan

AU - Tung, Nadine

AU - Rosen, Barry

AU - Gronwald, Jacek

AU - Ainsworth, Peter

AU - Sweet, Kevin

AU - Eisen, Andrea

AU - Sun, Ping

AU - Narod, Steven A.

PY - 2010/12/15

Y1 - 2010/12/15

N2 - Women who carry a deleterious mutation in BRCA1 or BRCA2 have high lifetime risks of breast and ovarian cancers. However, the influence of a family history of these cancers on these risks in women with BRCA mutations is unclear. We calculated cancer incidence rates for a multinational cohort comprising 3011 women with BRCA1 or BRCA2 mutations who were followed up for a mean of 3.9 years, during which time 243 incident breast or ovarian cancers were recorded. The 10-year cumulative risks of breast cancer were 18.1% (95% confidence interval [CI] = 13.3% to 22.8%) for women with a BRCA1 mutation and 15.2% (95% CI = 9.1% to 21.2%) for women with a BRCA2 mutation. Among women with a BRCA1 mutation, the risk of breast cancer increased by 1.2-fold for each first-degree relative with breast cancer before age 50 years (hazard ratio [HR] = 1.21; 95% confidence interval [CI] = 0.94 to 1.57) and the risk of ovarian cancer increased by 1.6 fold for each first- or second-degree relative with ovarian cancer (HR = 1.61; 95% CI = 1.21 to 2.14). Among women with a BRCA2 mutation, the risk of breast cancer increased by 1.7-fold for each first-degree relative younger than 50 years with breast cancer (HR = 1.67; 95% CI = 1.04 to 2.07).

AB - Women who carry a deleterious mutation in BRCA1 or BRCA2 have high lifetime risks of breast and ovarian cancers. However, the influence of a family history of these cancers on these risks in women with BRCA mutations is unclear. We calculated cancer incidence rates for a multinational cohort comprising 3011 women with BRCA1 or BRCA2 mutations who were followed up for a mean of 3.9 years, during which time 243 incident breast or ovarian cancers were recorded. The 10-year cumulative risks of breast cancer were 18.1% (95% confidence interval [CI] = 13.3% to 22.8%) for women with a BRCA1 mutation and 15.2% (95% CI = 9.1% to 21.2%) for women with a BRCA2 mutation. Among women with a BRCA1 mutation, the risk of breast cancer increased by 1.2-fold for each first-degree relative with breast cancer before age 50 years (hazard ratio [HR] = 1.21; 95% confidence interval [CI] = 0.94 to 1.57) and the risk of ovarian cancer increased by 1.6 fold for each first- or second-degree relative with ovarian cancer (HR = 1.61; 95% CI = 1.21 to 2.14). Among women with a BRCA2 mutation, the risk of breast cancer increased by 1.7-fold for each first-degree relative younger than 50 years with breast cancer (HR = 1.67; 95% CI = 1.04 to 2.07).

UR - http://www.scopus.com/inward/record.url?scp=78650409243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650409243&partnerID=8YFLogxK

U2 - 10.1093/jnci/djq443

DO - 10.1093/jnci/djq443

M3 - Article

C2 - 21098759

AN - SCOPUS:78650409243

VL - 102

SP - 1874

EP - 1878

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 24

ER -